The FDA is reviewing a possible link between the asthma drug Xolair and an increased risk of heart and cerebrovascular disorders.Since the FDA investigation is still under way, the agency is not telling doctors to stop prescribing Xolair and is not recommending any changes to the prescribing information for Xolair.
More...



Eileen Schoch traveled to her mother's funeral in Asheville, N.C. and found the hotel room —...
US regulators on Monday gave the green light to a pill version of the blockbuster weight-loss...
With subsidies for Affordable Care Act (ACA) health insurance set to expire, Americans who rely on...





























